N-HYBRIDE-COMPOSITE LC FLOW

K113444 · Voco GmbH · EBF · Dec 21, 2011 · Dental

Device Facts

• Record ID: K113444
• Device Name: N-HYBRIDE-COMPOSITE LC FLOW
• Applicant: Voco GmbH
• Product Code: EBF · Dental
• Decision Date: Dec 21, 2011
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 872.3690
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

n-hybrid-composite LC Flow is intended for use as: - filling minimally invasive cavities of all classes - filling small class I cavities and extended fissure sealing - filling class II-V cavities including V-shaped defects and cervical caries - - blocking out undercuts - - ﮮ lining or coating cavities - repairing fillings and veneers . - luting translucent prosthetic pieces (e.g. full ceramic crowns, etc.) -

Device Story

N-Hybrid-Composite LC Flow is a light-cured, flowable dental restorative material. Used by dentists in clinical settings for direct restorations, cavity lining, and luting of translucent prosthetics. Applied via syringe delivery system into prepared tooth cavities; cured using standard dental light-curing units. Provides structural filling and aesthetic repair for various cavity classes and defects. Benefits include improved handling for minimally invasive procedures and versatility in restorative applications.

Clinical Evidence

Bench testing only.

Technological Characteristics

Light-cured, flowable resin-based composite. Classified as tooth shade resin material (21 CFR 872.3690). Product codes EBF and EBC.

Indications for Use

Indicated for dental patients requiring restorative treatment for minimally invasive cavities, small class I cavities, fissure sealing, class II-V cavities, cervical caries, undercut blocking, cavity lining/coating, repair of fillings/veneers, and luting of translucent prosthetic pieces.

Regulatory Classification

Identification

Tooth shade resin material is a device composed of materials such as bisphenol-A glycidyl methacrylate (Bis-GMA) intended to restore carious lesions or structural defects in teeth.

Submission Summary (Full Text)

{0}------------------------------------------------

## DEPARTMENT OF HEALTH & HUMAN SERVICES

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

Dr. Thorsten Gerkensmeier Regulatory Affairs VOCO GmbH Anton-Flettner-Strasse 1-3 D-27472 Cuxhaven GERMANY

DEC 2011 2011

Re: K113444

Trade/Device Name: N-Hybrid-Composite LC Flow Regulation Number: 21 CFR 872.3690 Regulation Name: Tooth Shade Resin Material Regulatory Class: II Product Codes: EBF and EBC Dated: November 17, 2011 Received: November 21, 2011

Dear Dr. Gerkensmeier:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

## Page 2 -- Dr. Gerkensmeier

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices /ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.goy/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely vours.

Wh for

Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## Indications for Use Statement

510(k) Number: K113444

Device Name: _________________________________________________________________________________________________________________________________________________________________

Indications for Use:

n-hybrid-composite LC Flow is intended for use as:

- filling minimally invasive cavities of all classes
- filling small class I cavities and extended fissure sealing
- filling class II-V cavities including V-shaped defects and cervical caries -
- blocking out undercuts -
- ﮮ lining or coating cavities
- repairing fillings and veneers .
- luting translucent prosthetic pieces (e.g. full ceramic crowns, etc.) -

Prescription Use X

OR

Over-The-Counter Use

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

## Concurrence of CDRH, Office of Device Evaluation (ODE)

Swa Quora

(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices

510(k) Number: K113444